367 related articles for article (PubMed ID: 38619691)
1. Pathological progression of osteoarthritis: a perspective on subchondral bone.
Li X; Chen W; Liu D; Chen P; Wang S; Li F; Chen Q; Lv S; Li F; Chen C; Guo S; Yuan W; Li P; Hu Z
Front Med; 2024 Apr; 18(2):237-257. PubMed ID: 38619691
[TBL] [Abstract][Full Text] [Related]
2. Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Interface in Osteoarthritis.
Kovács B; Vajda E; Nagy EE
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546898
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of SDF-1α/CXCR4 Signalling in Subchondral Bone Attenuates Post-Traumatic Osteoarthritis.
Dong Y; Liu H; Zhang X; Xu F; Qin L; Cheng P; Huang H; Guo F; Yang Q; Chen A
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322244
[TBL] [Abstract][Full Text] [Related]
4. [Experimental study on the regulation of subchondral bone plate osteoprotegerin/receptor activator of nuclear factor kappa-B ligand system by berberine to retard the development of osteoarthritis in rabbits].
Zhang JF; Huang K; Cai HL; Zhang PL; Wang J
Zhongguo Gu Shang; 2022 May; 35(5):464-9. PubMed ID: 35535536
[TBL] [Abstract][Full Text] [Related]
5. New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?
Tat SK; Pelletier JP; Velasco CR; Padrines M; Martel-Pelletier J
Keio J Med; 2009 Mar; 58(1):29-40. PubMed ID: 19398882
[TBL] [Abstract][Full Text] [Related]
6. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
[TBL] [Abstract][Full Text] [Related]
7. SDF-1/CXCR4 axis coordinates crosstalk between subchondral bone and articular cartilage in osteoarthritis pathogenesis.
Qin HJ; Xu T; Wu HT; Yao ZL; Hou YL; Xie YH; Su JW; Cheng CY; Yang KF; Zhang XR; Chai Y; Yu B; Cui Z
Bone; 2019 Aug; 125():140-150. PubMed ID: 31108241
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of SDF-1/CXCR4 Axis to Alleviate Abnormal Bone Formation and Angiogenesis Could Improve the Subchondral Bone Microenvironment in Osteoarthritis.
Qin H; Zhao X; Hu YJ; Wang S; Ma Y; He S; Shen K; Wan H; Cui Z; Yu B
Biomed Res Int; 2021; 2021():8852574. PubMed ID: 34136574
[TBL] [Abstract][Full Text] [Related]
9. Role of the SDF-1/CXCR4 signaling pathway in cartilage and subchondral bone in temporomandibular joint osteoarthritis induced by overloaded functional orthopedics in rats.
Yang J; Li Y; Liu Y; Zhang Q; Zhang Q; Chen J; Yan X; Yuan X
J Orthop Surg Res; 2020 Aug; 15(1):330. PubMed ID: 32795379
[TBL] [Abstract][Full Text] [Related]
10. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits.
Lv Y; Xia JY; Chen JY; Zhao H; Yan HC; Yang HS; Li Q; Fan YX; Guo KJ; Chen XY
BMC Musculoskelet Disord; 2014 Nov; 15():370. PubMed ID: 25377946
[TBL] [Abstract][Full Text] [Related]
11. The expression of RANKL and OPG in the various grades of osteoarthritic cartilage.
Upton AR; Holding CA; Dharmapatni AA; Haynes DR
Rheumatol Int; 2012 Feb; 32(2):535-40. PubMed ID: 21259010
[TBL] [Abstract][Full Text] [Related]
12. Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis.
Bellido M; Lugo L; Roman-Blas JA; Castañeda S; Calvo E; Largo R; Herrero-Beaumont G
Osteoarthritis Cartilage; 2011 Oct; 19(10):1228-36. PubMed ID: 21820069
[TBL] [Abstract][Full Text] [Related]
13. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
Komuro H; Olee T; Kühn K; Quach J; Brinson DC; Shikhman A; Valbracht J; Creighton-Achermann L; Lotz M
Arthritis Rheum; 2001 Dec; 44(12):2768-76. PubMed ID: 11762937
[TBL] [Abstract][Full Text] [Related]
14. Osteoclasts are recruited to the subchondral bone in naturally occurring post-traumatic equine carpal osteoarthritis and may contribute to cartilage degradation.
Bertuglia A; Lacourt M; Girard C; Beauchamp G; Richard H; Laverty S
Osteoarthritis Cartilage; 2016 Mar; 24(3):555-66. PubMed ID: 26505663
[TBL] [Abstract][Full Text] [Related]
15. Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1β-stimulated human SW1353 chondrosarcoma cells.
Wang Z; Ding L; Zhang S; Jiang T; Yang Y; Li R
Int J Mol Med; 2014 Dec; 34(6):1720-6. PubMed ID: 25270538
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of the Tougu Xiaotong capsule on morphology and osteoprotegerin/nuclear factor-κB ligand expression in rabbits with knee osteoarthritis.
Chen S; Huang Y; Chen W; Wu G; Liao N; Li X; Huang M; Lin R; Yu C; Li X; Liu X
Mol Med Rep; 2016 Jan; 13(1):419-25. PubMed ID: 26573557
[TBL] [Abstract][Full Text] [Related]
17. Sotrastaurin, a PKC inhibitor, attenuates RANKL-induced bone resorption and attenuates osteochondral pathologies associated with the development of OA.
Pang C; Wen L; Qin H; Zhu B; Lu X; Luo S
J Cell Mol Med; 2020 Aug; 24(15):8452-8465. PubMed ID: 32652826
[TBL] [Abstract][Full Text] [Related]
18. The effect of postmenopausal osteoporosis on subchondral bone pathology in a rat model of knee osteoarthritis.
Wada H; Aso K; Izumi M; Ikeuchi M
Sci Rep; 2023 Feb; 13(1):2926. PubMed ID: 36804438
[TBL] [Abstract][Full Text] [Related]
19. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues.
Zupan J; Komadina R; Marc J
J Biomed Sci; 2012 Mar; 19(1):28. PubMed ID: 22380539
[TBL] [Abstract][Full Text] [Related]
20. [Subchondral bone in osteoarthritis: a review].
Pang J; Cao YL; Shi YY
Zhongguo Gu Shang; 2011 Aug; 24(8):702-4. PubMed ID: 21928687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
